Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke （Japan Alteplase Clinical Trial Ⅱ：J-ACT Ⅱ）

NCT00412867 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Stroke

Interventions

DRUG: Alteplase

Sponsor

Tanabe Pharma Corporation

Collaborators

[object Object]